A Pilot/Safety Study of sEphB4-Hsa in Combination with a Hypomethylating Agent for Patients with Relapsed or Refractory Myelodysplastic Syndrome and Acute Myeloid Leukemia Previously Treated with a Hypomethylating Agent
- Resource Type
- Abstract
- Source
- In
Blood 5 November 2020 136 Supplement 1:40-41 - Subject
- Language
- ISSN
- 0006-4971